Hostname: page-component-84b7d79bbc-5lx2p Total loading time: 0 Render date: 2024-08-05T06:22:01.710Z Has data issue: false hasContentIssue false
  • English
  • Français

Practical Applications of Decision Analysis

Published online by Cambridge University Press:  21 June 2016

Mary D. Nettleman
Mary D. Nettleman*
Affiliation:
Division of Clinical Epidemiology, Department of Internal Medicine, The University of Iowa Hospitals and Clinics, Iowa City, Iowa
*
Division of Clinical Epidemiology, C41 GH, The University of Iowa Hospitals and Clinics, Iowa City, IA 52242
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 9 , Issue 5 , May 1988 , pp. 214 - 218
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Rogan, WJ, Gladen, B: Estimating prevalence from the results of a screening test. Am J Epidemiol 1978; 107:71–76.CrossRefGoogle ScholarPubMed
2. Fryback, DG, Thornbury, JR: Informal use of decision theory to improve radiological patient management. Radiology 1978; 129:385–388.CrossRefGoogle ScholarPubMed
3. Mulley, AG, Silverstein, MD, Dienstag, JL: Indications for use of hepatitis 16 vaccine, based on cost-effectiveness analysis. N Engl J Med 1982; 307:644–652.CrossRefGoogle Scholar
4. Hadler, SC, et al: Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986; 315:2009–2014.CrossRefGoogle ScholarPubMed
5 Immunization Practices Advisory Committee: Update of hepatitis B prevention. MMWR 1987; 36:353–365.Google Scholar
6. Arevalo, JA, Washington, AE: Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA 1988: 259:365–369.CrossRefGoogle ScholarPubMed
7. Dienstag, JL, Werner, BG, Polk, BF, et al: Hepatitis B vaccine in health care personnel: Safety, immunogenicity and indicators of efficacy. Ann Intern Med 1984; 101:34–40.CrossRefGoogle Scholar
8. Thompson, SE, Washington, AE: Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev 1983; 5:96–123.CrossRefGoogle ScholarPubMed
9. Nettleman, MD, Jones, RB, Roberts, SD, et al: Cost-effectiveness of culturing for Chlamydia trachomatis . Ann Intern Med 1986; 105:189–196.CrossRefGoogle ScholarPubMed
10. Nettleman, M. Jones, R, Roberts, S, et al: Cost-effectiveness of serology and cell culture for Chlamydia trachomatis in low prevalence women, in Human Chlamydial Infection, Cambridge, Cambridge University Press, 1986, pp 205–208.Google Scholar
II. Schachter, J, Sweet, RL. Grossman, M, et al: Experience with the routine use of erythromycin for chlamydial infections in pregnancy. N Engl J Med 1986; 314:276–279.CrossRefGoogle ScholarPubMed
12. Smith, JW, Rogers, RE, Katz, BP, et al: Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol 1987: 25:868–872.CrossRefGoogle ScholarPubMed
13. Harrison, HR, Alexander, ER: Chlamydia trachomatis infections of the infant, in Holmes, KK, Mardh, P-A, Sparling, PF, et al (eds): Sexually Transmitted Diseases. New York, McGraw-Hill, 1984 Google Scholar